Abstract
Proposed changes to the Common Rule would require publicly funded researchers to disclose whether a subject's biospecimens could be used for commercial profit and whether the subject will share in those proceeds. Disclosing commercial interests will inform research participants that their tissue may have commercial value, a possibility that those individuals might not have previously considered. The proposed changes may then provide people with an opportunity to negotiate commercial rights in their biospecimens despite the well-accepted legal precedent that individuals maintain no interests in their excised tissue.
Publisher
Cambridge University Press (CUP)
Subject
Health Policy,General Medicine,Issues, ethics and legal aspects
Reference15 articles.
1. Genes and Spleens: Property, Contract, or Privacy Rights in the Human Body?
2. 5. Greenberg v. Miami Children's Hosp., 264 F. Supp. 2d 1064 (S.D. Fla. 2003).
3. 4. Carlson, P. , “A Seattle Man Vents His Spleen Against Those Who Would Use It for Profit,” People Magazine, September 23, 1985.
4. 11. 45 C.F.R. §§ 46.101(a), 46.122.
5. Untapped Potential: IRB Guidance for the Ethical Research Use of Stored Biological Materials
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献